trihexyphenidyl has been researched along with Idiopathic Parkinson Disease in 172 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of the anti-parkinsonian drug trihexyphenidyl (THP) to treat patients with Parkinson's disease (PD), particularly those with tremor-dominant PD (tdPD), has been well documented." | 8.12 | Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study. ( Hao, X; Li, T; Liang, Z; Liu, W; Lu, R; Pu, L; Wang, HY, 2022) |
| "We report a 71-year-old woman with tactile hallucinations induced by trihexyphenidyl." | 7.73 | [Tactile hallucinations induced by trihexyphenidyl in a patient with Parkinson's disease]. ( Funakawa, I; Jinnai, K, 2005) |
| "A 55-year-old man with idiopathic Parkinson's disease developed myasthenia gravis shortly after taking trihexyphenidyl." | 7.67 | Parkinson's disease and myasthenia gravis: adverse effect of trihexyphenidyl on neuromuscular transmission. ( Hazama, T; Kajiyama, K; Okahisa, N; Takahashi, M; Tarui, S; Ueno, S; Yorifuji, S, 1987) |
| "An electromyographic method was used to study the effect of combination therapy with L-dopa and trihexyphenidyl on tremor in thirty patients suffering from extrapyramidal motor system disease." | 7.66 | Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor. ( Hökendorf, H, 1979) |
| "However, pneumonia combined with malignant hyperthermia and SIADH has rarely been reported." | 5.56 | Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report. ( Chen, Y; Feng, C; Kang, Y; Liu, F; Ma, W; Xu, G; Zhao, J, 2020) |
| "The effect of long-acting propranolol hydrochloride (160 mg/d), primidone (250 mg at night), and clonazepam (4 mg/d) on the resting, postural, and kinetic component of tremor was investigated in ten parkinsonian patients in a double-blind crossover design." | 5.06 | Adjuvant therapy of parkinsonian tremor. ( Herbster, G; Koller, WC, 1987) |
| "The use of the anti-parkinsonian drug trihexyphenidyl (THP) to treat patients with Parkinson's disease (PD), particularly those with tremor-dominant PD (tdPD), has been well documented." | 4.12 | Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study. ( Hao, X; Li, T; Liang, Z; Liu, W; Lu, R; Pu, L; Wang, HY, 2022) |
| "We report a 71-year-old woman with tactile hallucinations induced by trihexyphenidyl." | 3.73 | [Tactile hallucinations induced by trihexyphenidyl in a patient with Parkinson's disease]. ( Funakawa, I; Jinnai, K, 2005) |
| " In this study the anticholinergic drug, trihexyphenidyl, at low doses when administered chronically for one month to Parkinson disease patients caused a decrease in performance on recent but not immediate memory tests." | 3.67 | Disturbance of recent memory function in parkinsonian patients on anticholinergic therapy. ( Koller, WC, 1984) |
| "A 55-year-old man with idiopathic Parkinson's disease developed myasthenia gravis shortly after taking trihexyphenidyl." | 3.67 | Parkinson's disease and myasthenia gravis: adverse effect of trihexyphenidyl on neuromuscular transmission. ( Hazama, T; Kajiyama, K; Okahisa, N; Takahashi, M; Tarui, S; Ueno, S; Yorifuji, S, 1987) |
| "The relative efficacy of trihexiphenidyl hydrochloride, amantadine hydrochloride, and low-dose carbidopa-levodopa in reducing parkinsonian tremor was investigated using objective techniques." | 3.67 | Pharmacologic treatment of parkinsonian tremor. ( Koller, WC, 1986) |
| "An electromyographic method was used to study the effect of combination therapy with L-dopa and trihexyphenidyl on tremor in thirty patients suffering from extrapyramidal motor system disease." | 3.66 | Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor. ( Hökendorf, H, 1979) |
| "3." | 2.64 | Nomifensine in Parkinson's disease. ( Bedard, P; Marsden, CD; Parkes, JD, 1977) |
| " Hence we would advise that if for any reason anticholinergic drugs are to be withdrawn in patients receiving a stable dosage of levodopa this must be done slowly." | 2.64 | Levodopa in Parkinsonism: the effects of withdrawal of anticholinergic drugs. ( Hughes, RC; Polgar, JG; Walton, JN; Weightman, D, 1971) |
| "Current long-term treatment of Parkinson's disease is inadequate, and improved symptomatic and neuroprotective therapies are needed." | 2.38 | N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease. ( Greenamyre, JT; O'Brien, CF, 1991) |
| "The treatment of Parkinson's disease today is complex, time-consuming, but rewarding." | 2.35 | Advances in the management of parkinson's disease. ( Marsden, CD, 1976) |
| "However, pneumonia combined with malignant hyperthermia and SIADH has rarely been reported." | 1.56 | Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report. ( Chen, Y; Feng, C; Kang, Y; Liu, F; Ma, W; Xu, G; Zhao, J, 2020) |
| "Paroxysmal exercise-induced dystonia (PED) is a rare, typically idiopathic familial condition, although sporadic and secondary cases have been reported." | 1.32 | Paroxysmal exercise-induced dystonia as a presenting feature of young-onset Parkinson's disease. ( Bhatia, KP; Bozi, M, 2003) |
| "Trihexyphenidyl (THP) is a drug commonly used to reduce parkinsonian symptoms." | 1.32 | Treatment with subthreshold doses of caffeine plus trihexyphenidyl fully restores locomotion and exploratory activity in reserpinized rats. ( Alvarez-Cervera, F; Arankowsky-Sandoval, G; Góngora-Alfaro, JL; Moo-Puc, RE; Villanueva-Toledo, J, 2004) |
| "We report a patient with Parkinson's disease who developed orobuccal dyskinesia while being treated with trihexyphenidyl (Artane)." | 1.29 | Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease. ( Hauser, RA; Olanow, CW, 1993) |
| "We investigated a patient with Parkinson's disease accompanied by intellectual impairment induced by long-term AC therapy." | 1.29 | Positron emission tomography of reversible intellectual impairment induced by long-term anticholinergic therapy. ( Momose, T; Nishiyama, K; Sakuta, M; Sugishita, M, 1995) |
| "Groups of patients with Parkinson's disease, either medicated, or unmedicated and early in the course, together with age- and IQ-matched control subjects were tested in two paradigms measuring different aspects of selective attention." | 1.28 | Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. ( Downes, JJ; Evenden, JL; Morris, RG; Robbins, TW; Roberts, AC; Sahakian, BJ, 1989) |
| "Two patients with Parkinson's disease are reported, in whom painful sensory phenomena preceded or accompanied the disease process." | 1.27 | Anticholinergic-induced analgesia: possible role for the cholinergic system in abnormal sensory symptoms in Parkinson's disease. ( Sandyk, R, 1986) |
| "It is important that Parkinson's disease be considered in the differential diagnosis of a progressively evolving hemiparesis." | 1.26 | A pseudohemipharetic form of Parkinson's disease. ( Gilbert, GJ, 1976) |
| "A patient with confirmed western equine encephalitis had the rapid onset of postencephalitic parkinsonian sequelae." | 1.26 | Western equine encephalitis with rapid onset of parkinsonism. ( Barthal, JS; Garrett, G; Schultz, DR, 1977) |
| " Although directly related to daily dosage of levodopa, the myoclonus was specifically blocked by the serotonin antagonist, methysergide." | 1.25 | Levodopa-induced myoclonus. ( Bergen, D; Goetz, C; Klawans, HL, 1975) |
| "The most disabling form of Parkinsonism is that occurring after encephalitis." | 1.23 | Therapy of Parkinson's disease. ( VAN METER, JR, 1950) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 133 (77.33) | 18.7374 |
| 1990's | 23 (13.37) | 18.2507 |
| 2000's | 9 (5.23) | 29.6817 |
| 2010's | 4 (2.33) | 24.3611 |
| 2020's | 3 (1.74) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, HY | 3 |
| Hao, X | 3 |
| Lu, R | 3 |
| Li, T | 3 |
| Pu, L | 3 |
| Liu, W | 3 |
| Liang, Z | 3 |
| Zhao, J | 1 |
| Xu, G | 1 |
| Feng, C | 1 |
| Chen, Y | 1 |
| Kang, Y | 1 |
| Liu, F | 1 |
| Ma, W | 1 |
| Sahoo, LK | 1 |
| Holla, VV | 1 |
| Batra, D | 1 |
| Prasad, S | 1 |
| Bhattacharya, A | 1 |
| Kamble, N | 1 |
| Yadav, R | 1 |
| Pal, PK | 2 |
| Lefaucheur, R | 1 |
| Le Goff, F | 1 |
| Gaillon, G | 1 |
| Triquenot-Bagan, A | 1 |
| Maltête, D | 1 |
| Prashantha, DK | 1 |
| Zhe, X | 1 |
| Qu, QM | 1 |
| Wang, RL | 1 |
| Cao, HM | 1 |
| Qiao, J | 1 |
| Guo, F | 1 |
| Herzallah, MM | 1 |
| Moustafa, AA | 1 |
| Misk, AJ | 1 |
| Al-Dweib, LH | 1 |
| Abdelrazeq, SA | 1 |
| Myers, CE | 1 |
| Gluck, MA | 1 |
| Hashim, HZ | 1 |
| Wan Musa, WR | 1 |
| Ngiu, CS | 1 |
| Wan Yahya, WN | 1 |
| Tan, HJ | 1 |
| Ibrahim, N | 1 |
| Baba, Y | 1 |
| Higuchi, MA | 1 |
| Abe, H | 1 |
| Fukuyama, K | 1 |
| Onozawa, R | 1 |
| Uehara, Y | 1 |
| Inoue, T | 1 |
| Yamada, T | 1 |
| SCHULSINGER, F | 1 |
| SEGARD, M | 1 |
| SIGURET, G | 1 |
| HOLT, CL | 1 |
| DOSHAY, LJ | 4 |
| CONSTABLE, K | 3 |
| ZIER, A | 3 |
| KAPLAN, HA | 1 |
| MACHOVER, S | 1 |
| RABINER, A | 1 |
| SCHMIDT, P | 1 |
| DE MAAR, EW | 1 |
| VON KEYSERLINGK, H | 1 |
| PORTEOUS, HB | 1 |
| ROSS, DN | 1 |
| HARDER, A | 1 |
| PRELICZ, T | 1 |
| BERGER, H | 2 |
| KIRCHHOF, JK | 2 |
| RASHKIS, HA | 1 |
| SMARR, ER | 1 |
| KAFER, JP | 1 |
| POCH, GF | 1 |
| NAHUNEK, K | 1 |
| RYBAKOVA, V | 1 |
| KONCHEGUL, L | 1 |
| EDWARDS, CE | 1 |
| O'DOHERTY, DS | 2 |
| COOPER, IS | 1 |
| Tanaka, M | 1 |
| Okamoto, K | 1 |
| AKIMOTO, H | 1 |
| SHIKIBA, S | 1 |
| NAGAO, T | 1 |
| NARABAYASHI, H | 1 |
| SCHWAB, RS | 2 |
| PAKKENBERG, H | 2 |
| POLEZHAEVA, AI | 1 |
| HAFFNER, Z | 1 |
| POPPEL, A | 1 |
| WALKER, LG | 1 |
| HIEBERT, T | 1 |
| SMYTH, NP | 1 |
| GILLINGHAM, FJ | 1 |
| KALYANARAMAN, S | 1 |
| BURNS, BD | 1 |
| DEJONG, D | 1 |
| SOLIS-QUIROGA, OH | 1 |
| MEYER, JS | 1 |
| MAGEE, KR | 1 |
| STRANG, RR | 2 |
| LERNER, PF | 1 |
| MANDEL, W | 2 |
| CLAFFEY, B | 1 |
| MARGOLIS, LH | 1 |
| OLIVER, WA | 1 |
| Bozi, M | 1 |
| Bhatia, KP | 1 |
| VAN METER, JR | 1 |
| EFFRON, AS | 1 |
| FARQUHAR, JW | 1 |
| ALONSO FERNANDEZ, F | 1 |
| BERKOWITZ, B | 1 |
| ALVERMANN, E | 1 |
| PIAZZESI, W | 1 |
| WRIGHT, WB | 1 |
| Moo-Puc, RE | 1 |
| Villanueva-Toledo, J | 1 |
| Arankowsky-Sandoval, G | 1 |
| Alvarez-Cervera, F | 1 |
| Góngora-Alfaro, JL | 1 |
| REMOUCHAMPS, L | 1 |
| VERBEKE, R | 1 |
| Funakawa, I | 1 |
| Jinnai, K | 1 |
| TILLMANN, WR | 1 |
| Preskorn, SH | 2 |
| Winer, JA | 1 |
| Bahn, S | 1 |
| Mancall, EL | 1 |
| Covington, TR | 1 |
| Alonso, RJ | 1 |
| Koller, WC | 3 |
| Kehr, W | 1 |
| Pavoncello, S | 1 |
| Di Bianco, V | 1 |
| Di Castro, A | 1 |
| Caviglia, A | 1 |
| Cellitti, M | 1 |
| Mitsui, T | 1 |
| Kawai, H | 1 |
| Sakoda, S | 1 |
| Miyata, M | 1 |
| Saito, S | 1 |
| Krack, P | 1 |
| Marion, MH | 1 |
| Linazasoro, G | 1 |
| Hineno, T | 1 |
| Mizobuchi, M | 1 |
| Nishimatsu, O | 1 |
| Horiguchi, J | 1 |
| Kakimoto, Y | 1 |
| Hauser, RA | 1 |
| Olanow, CW | 1 |
| Noda, K | 1 |
| Isozaki, E | 1 |
| Miyamoto, K | 1 |
| Hirose, K | 1 |
| Tanabe, H | 1 |
| Oda, M | 1 |
| Kao, KP | 1 |
| Kwan, SY | 1 |
| Lin, KP | 1 |
| Chang, YC | 1 |
| Nishiyama, K | 2 |
| Mizuno, T | 1 |
| Sakuta, M | 2 |
| Kurisaki, H | 1 |
| Van Spaendonck, KP | 1 |
| Berger, HJ | 1 |
| Horstink, MW | 1 |
| Buytenhuijs, EL | 1 |
| Cools, AR | 1 |
| Momose, T | 1 |
| Sugishita, M | 1 |
| Gorchein, A | 1 |
| Shinotoh, H | 1 |
| Asahina, M | 1 |
| Inoue, O | 1 |
| Suhara, T | 1 |
| Hirayama, K | 2 |
| Tateno, Y | 1 |
| Kishore, A | 1 |
| Snow, BJ | 1 |
| Kirollos, C | 1 |
| Charlett, A | 1 |
| O'Neill, CJ | 1 |
| Kosik, R | 1 |
| Mozol, K | 1 |
| Purkiss, AG | 1 |
| Bowes, SG | 1 |
| Nicholson, PW | 1 |
| Hunt, WB | 1 |
| Weller, C | 1 |
| Dobbs, SM | 1 |
| Dobbs, RJ | 1 |
| van Laar, T | 1 |
| Lammers, GJ | 1 |
| Roos, RA | 1 |
| Gerritsen, JJ | 1 |
| Meinders, AE | 1 |
| Izurieta-Sánchez, P | 1 |
| Sarre, S | 1 |
| Ebinger, G | 1 |
| Michotte, Y | 1 |
| Bédard, MA | 1 |
| Pillon, B | 1 |
| Dubois, B | 1 |
| Duchesne, N | 1 |
| Masson, H | 1 |
| Agid, Y | 1 |
| Takahashi, S | 1 |
| Tohgi, H | 1 |
| Yonezawa, H | 1 |
| Obara, S | 1 |
| Yamazaki, E | 1 |
| Shad, MU | 1 |
| Marsh, C | 1 |
| Sakakibara, R | 1 |
| Uchiyama, T | 1 |
| Yoshiyama, M | 1 |
| Hattori, T | 1 |
| Greer, M | 1 |
| Gilbert, GJ | 1 |
| Ludin, HP | 2 |
| Ringwald, E | 2 |
| Lörincz, P | 2 |
| Barbeau, A | 1 |
| Campanella, G | 1 |
| Butterworth, RF | 1 |
| Yamada, K | 1 |
| Taylor, J | 1 |
| Bedard, P | 1 |
| Parkes, JD | 4 |
| Marsden, CD | 6 |
| Hökendorf, H | 1 |
| Mace, M | 1 |
| Rawlins, MD | 1 |
| Schultz, DR | 1 |
| Barthal, JS | 1 |
| Garrett, G | 1 |
| Mindham, RH | 1 |
| Kunz, F | 1 |
| Blonsky, ER | 2 |
| Butzer, JF | 1 |
| Silver, DE | 1 |
| Sahs, AL | 1 |
| Lukasiewicz, K | 1 |
| Allen, N | 1 |
| Knopp, W | 2 |
| Bianchine, JR | 1 |
| Evtushenko, SK | 1 |
| Klawans, HL | 2 |
| Goetz, C | 1 |
| Bergen, D | 1 |
| Algeri, S | 1 |
| Cerletti, C | 1 |
| Curcio, M | 1 |
| Morselli, PL | 2 |
| Bonollo, L | 1 |
| Buniva, G | 1 |
| Minazzi, M | 1 |
| Minoli, G | 1 |
| Stimmel, GL | 1 |
| Parkenberg, H | 1 |
| Jordan, N | 1 |
| Sagar, HJ | 1 |
| Cooper, JA | 1 |
| Schelosky, L | 1 |
| Benke, T | 1 |
| Poewe, WH | 1 |
| Greenamyre, JT | 1 |
| O'Brien, CF | 1 |
| Nakashima, K | 1 |
| Takahashi, K | 1 |
| Fahn, S | 2 |
| Burke, R | 1 |
| Stern, Y | 1 |
| Sandyk, R | 1 |
| Downes, JJ | 1 |
| Roberts, AC | 1 |
| Sahakian, BJ | 1 |
| Evenden, JL | 1 |
| Morris, RG | 1 |
| Robbins, TW | 1 |
| Ueno, S | 1 |
| Takahashi, M | 1 |
| Kajiyama, K | 1 |
| Okahisa, N | 1 |
| Hazama, T | 1 |
| Yorifuji, S | 1 |
| Tarui, S | 1 |
| Yamamoto, K | 1 |
| Noda, S | 1 |
| Umezaki, H | 1 |
| Giménez-Roldán, S | 1 |
| Mateo, D | 1 |
| Orbe, M | 1 |
| Muñoz-Blanco, JL | 1 |
| Hípola, D | 1 |
| Meerwaldt, JD | 1 |
| Hovestadt, A | 1 |
| Herbster, G | 1 |
| Sunohara, N | 1 |
| Mano, Y | 1 |
| Ando, K | 1 |
| Satoyoshi, E | 1 |
| Agnoli, A | 2 |
| Casacchia, M | 2 |
| Ruggieri, S | 2 |
| Volante, F | 2 |
| Accornero, N | 2 |
| Mano, T | 1 |
| Birket-Smith, E | 1 |
| Alstead, S | 1 |
| Oelszner, W | 1 |
| Walther, H | 1 |
| Wagner, U | 1 |
| Girard, P | 1 |
| Mansuy, L | 1 |
| Garde, A | 1 |
| Lapras, R | 1 |
| Naylor, RJ | 1 |
| Costall, B | 1 |
| Lavy, S | 1 |
| Marks, ES | 1 |
| Abramsky, O | 1 |
| Muenter, MD | 2 |
| Sharpless, NS | 2 |
| Tyce, GM | 2 |
| Dinapoli, RP | 1 |
| Benesová, O | 1 |
| Brown, DM | 1 |
| Hughes, BO | 1 |
| Meadows, JC | 1 |
| Spicer, B | 1 |
| Ericsson, AD | 1 |
| McKinney, AS | 1 |
| Rix, A | 2 |
| Wang, RI | 1 |
| Rimm, AA | 1 |
| Presthus, J | 1 |
| Martin, WE | 1 |
| Loewenson, RB | 1 |
| Resch, JA | 1 |
| Baker, AB | 1 |
| Dreyfuss, J | 1 |
| Beer, B | 1 |
| Devine, DD | 1 |
| Roberts, BF | 1 |
| Schreiber, EC | 1 |
| Freeman, H | 1 |
| Mehta, IS | 1 |
| Ciuca, I | 1 |
| Bulandra, R | 1 |
| Serbanesco, A | 1 |
| Ninosu, N | 1 |
| Wolf, SM | 1 |
| Davis, RL | 1 |
| Martinez, AJ | 1 |
| Utterback, RA | 1 |
| Papavasiliou, PS | 1 |
| Cotzias, GC | 1 |
| Lawrence, WH | 1 |
| Brait, K | 1 |
| Schwarz, GA | 1 |
| Siegfried, J | 1 |
| Horrocks, PM | 1 |
| Vicary, DJ | 1 |
| Rees, JE | 2 |
| Chase, TN | 1 |
| Woods, AC | 1 |
| Glaubiger, GA | 1 |
| Wilcox, CS | 1 |
| Aminoff, MJ | 1 |
| Kurtz, AB | 1 |
| Slater, JD | 1 |
| Baxter, RC | 1 |
| Stoliarova, LG | 1 |
| Uono, M | 1 |
| Nakanishi, T | 1 |
| Kato, N | 1 |
| Nagao, Y | 1 |
| Friedman, Z | 1 |
| Neumann, E | 1 |
| Muscettola, GB | 1 |
| Giovannucci, M | 1 |
| Montanini, R | 1 |
| Garattini, S | 1 |
| Fisher, RG | 1 |
| Ban, T | 1 |
| Hojo, M | 1 |
| Pecknold, JC | 1 |
| Ananth, JV | 1 |
| Ban, TA | 1 |
| Lehmann, HE | 1 |
| Stelmasiak, Z | 1 |
| Lackowska, H | 1 |
| Maksymowicz, B | 1 |
| Orlov, P | 1 |
| Kasparian, G | 1 |
| DiMascio, A | 1 |
| Cole, JO | 1 |
| Kaufmann, W | 1 |
| Butz, P | 1 |
| Wiesendanger, M | 1 |
| Weintraub, MI | 1 |
| Van Woert, MH | 1 |
| Gjerris, F | 1 |
| Maller, O | 1 |
| Heller, S | 1 |
| Hughes, RC | 1 |
| Polgar, JG | 1 |
| Weightman, D | 1 |
| Walton, JN | 1 |
| Vestberg, F | 1 |
| Stern, M | 1 |
| Roffwarg, H | 1 |
| Duvoisin, R | 1 |
| Dandiya, PC | 1 |
| Bhargava, LP | 1 |
| Duvoisin, RC | 1 |
| Katz, R | 1 |
| Hader, M | 1 |
| Grabowski, K | 1 |
9 reviews available for trihexyphenidyl and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
CURRENT VIEWS CONCERNING THE ETIOLOGY, PATHOPHYSIOLOGY, AND TREATMENT OF PARKINSON'S DISEASE.
Topics: Classification; Drug Therapy; Muscle Relaxants, Central; Neurosurgery; Neurosurgical Procedures; Par | 1964 |
Drug management of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Selegiline; Tr | 1996 |
[Disturbance of micturition in Parkinson's disease].
Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middl | 2001 |
Advances in the management of parkinson's disease.
Topics: Amantadine; Anesthesia; Humans; Levodopa; Orphenadrine; Parasympatholytics; Parkinson Disease; Socia | 1976 |
N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease.
Topics: Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; gamma-Aminobutyric Acid; Globus Pallidus; H | 1991 |
Antimuscarinic drugs in the treatment of movement disorders.
Topics: Adult; Attention; Dystonia; Humans; Memory; Movement Disorders; Parasympatholytics; Parkinson Diseas | 1990 |
The pharmacology of parkinsonism (a review).
Topics: Acetylcholine; Animals; Atropa belladonna; Atropine; Central Nervous System; Chlorpromazine; Dextroa | 1968 |
[Review of current pharmacotherapy of Parkinsonism. Comprehensive review].
Topics: 5-Hydroxytryptophan; Amantadine; Anticonvulsants; Apomorphine; Benztropine; Carboxy-Lyases; Chemical | 1973 |
[Factors which influence infavourably l-dopa treatment].
Topics: Administration, Oral; Dihydroxyphenylalanine; Drug Synergism; Drug Therapy, Combination; Humans; Par | 1973 |
23 trials available for trihexyphenidyl and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female | 1996 |
Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome.
Topics: Acute Disease; Cholinergic Antagonists; Cognition Disorders; Corpus Striatum; Cross-Over Studies; Do | 1999 |
Bromocriptine in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Le | 1978 |
Nomifensine in Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Isoquin | 1977 |
Psychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disability.
Topics: Aged; Amantadine; Carbidopa; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; | 1976 |
[Clinical experience with bromocriptine, a central dopaminergic stimulator].
Topics: Aged; Amantadine; Bromocriptine; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Respo | 1976 |
Elantrine in the treatment of parkinsonism.
Topics: Adult; Aged; Clinical Trials as Topic; Dibenzazepines; Drug Evaluation; Female; Humans; Male; Middle | 1976 |
Amantadine in Parkinson's disease. A double-blind, placebo-controlled, crossover study with long-term follow-up.
Topics: Activities of Daily Living; Aged; Amantadine; Benztropine; Clinical Trials as Topic; Diphenhydramine | 1975 |
Adjuvant therapy of parkinsonian tremor.
Topics: Aged; Antiparkinson Agents; Carbidopa; Clonazepam; Double-Blind Method; Drug Therapy, Combination; H | 1987 |
Drug therapy in parkinsonism.
Topics: Clinical Trials as Topic; Drug Tolerance; Humans; Parkinson Disease; Trihexyphenidyl | 1970 |
3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
Topics: Aged; Clinical Trials as Topic; Dihydroxyphenylalanine; Disability Evaluation; Drug Interactions; Fe | 1973 |
Some initial animal and human pharmacological studies with benapryzine (BRL 1288).
Topics: Acetylcholine; Aged; Animals; Antiparkinson Agents; Benzilates; Clinical Trials as Topic; Dose-Respo | 1973 |
Phase II multiclinic study of elantrine in parkinsonism.
Topics: Aged; Antiparkinson Agents; Clinical Trials as Topic; Dibenzazepines; Dimethylamines; Female; Humans | 1974 |
A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
Topics: Affective Symptoms; Aged; Anxiety; Clinical Trials as Topic; Confusion; Drug Evaluation; Drug Therap | 1974 |
A double-blind comparison of the efficacy of EX 10-029 and trihexyphenidyl hydrochloride in relieving drug-induced Parkinsonian symptoms.
Topics: Antiparkinson Agents; Clinical Trials as Topic; Female; Humans; Male; Methods; Middle Aged; Parkinso | 1972 |
[Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
Topics: Amantadine; Antiparkinson Agents; Dihydroxyphenylalanine; Drug Combinations; Drug Synergism; Humans; | 1972 |
Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease.
Topics: Adult; Aged; Dihydroxyphenylalanine; Disability Evaluation; Drug Synergism; Evaluation Studies as To | 1973 |
Parkinson disease treated with a suspected dopamine receptor agonist.
Topics: Adult; Aged; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benztropine; Dihydroxyphenyla | 1974 |
[Treatment of parkinsonism with the Bulgarian preparations INHA-17 and bellazon].
Topics: Adult; Aged; Atropa belladonna; Clinical Trials as Topic; Humans; Isoniazid; Middle Aged; Parasympat | 1966 |
Psychiatric changes in patients treated with levodopa. I. The clinical experiment.
Topics: Activities of Daily Living; Adjustment Disorders; Aged; Amitriptyline; Clinical Trials as Topic; Dia | 1970 |
[Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
Topics: Administration, Oral; Adolescent; Adult; Aged; Analysis of Variance; Clinical Trials as Topic; Dihyd | 1971 |
Neutralization of extrapyramidal side-effects with Methixene.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Extrapyramidal Tracts; Female; Humans; Male; Middle Age | 1971 |
Levodopa in Parkinsonism: the effects of withdrawal of anticholinergic drugs.
Topics: Dihydroxyphenylalanine; Drug Synergism; Drug Tolerance; Female; Humans; Male; Methods; Neurologic Ma | 1971 |
140 other studies available for trihexyphenidyl and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study.
Topics: Cognition; Executive Function; Humans; Parkinson Disease; Tremor; Trihexyphenidyl | 2022 |
Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study.
Topics: Cognition; Executive Function; Humans; Parkinson Disease; Tremor; Trihexyphenidyl | 2022 |
Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study.
Topics: Cognition; Executive Function; Humans; Parkinson Disease; Tremor; Trihexyphenidyl | 2022 |
Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study.
Topics: Cognition; Executive Function; Humans; Parkinson Disease; Tremor; Trihexyphenidyl | 2022 |
Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study.
Topics: Cognition; Executive Function; Humans; Parkinson Disease; Tremor; Trihexyphenidyl | 2022 |
Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study.
Topics: Cognition; Executive Function; Humans; Parkinson Disease; Tremor; Trihexyphenidyl | 2022 |
Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study.
Topics: Cognition; Executive Function; Humans; Parkinson Disease; Tremor; Trihexyphenidyl | 2022 |
Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study.
Topics: Cognition; Executive Function; Humans; Parkinson Disease; Tremor; Trihexyphenidyl | 2022 |
Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study.
Topics: Cognition; Executive Function; Humans; Parkinson Disease; Tremor; Trihexyphenidyl | 2022 |
Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report.
Topics: Antiparkinson Agents; Humans; Hyponatremia; Male; Malignant Hyperthermia; Middle Aged; Parkinson Dis | 2020 |
Comparison of effectiveness of trihexyphenidyl and levodopa on motor symptoms in Parkinson's disease.
Topics: Antiparkinson Agents; Humans; Hypokinesia; Infant, Newborn; Levodopa; Parkinson Disease; Treatment O | 2020 |
Severe dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?
Topics: Anticoagulants; Antiparkinson Agents; Biotransformation; Dizziness; Drug Interactions; Drug Substitu | 2015 |
Serpentine tongue: A rare manifestation following initiation of levodopa therapy in a patient with Parkinson's disease.
Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parkinson Disea | 2009 |
[The use of antiparkinsonism drugs in 92 cases in Xi'an city].
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; China; Dopamine Agon | 2009 |
Depression impairs learning whereas anticholinergics impair transfer generalization in Parkinson patients tested on dopaminergic medications.
Topics: Aged; Cholinergic Antagonists; Depression; Dopamine Agonists; Female; Humans; Learning; Male; Middle | 2010 |
Parkinsonism complicating acute organophosphate insecticide poisoning.
Topics: Acute Disease; Adult; Antidotes; Antiparkinson Agents; Benserazide; Cholinesterase Inhibitors; Human | 2011 |
Anti-cholinergics for axial symptoms in Parkinson's disease after subthalamic stimulation.
Topics: Activities of Daily Living; Aged; Cholinergic Antagonists; Deep Brain Stimulation; Female; Humans; M | 2012 |
[Artane therapy of paralysis agitans].
Topics: Parkinson Disease; Trihexyphenidyl | 1952 |
[Therapeutic diagrams].
Topics: Antipsychotic Agents; Heterocyclic Compounds; Parkinson Disease; Phenothiazines; Trihexyphenidyl | 1953 |
Spider angiomas appearing during treatment with trihexyphenidyl.
Topics: Animals; Hemangioma; Humans; Parkinson Disease; Spiders; Trihexyphenidyl | 1953 |
Five year follow-up of treatment with trihexyphenidyl (artane); outcome in four hundred eleven cases of paralysis agitans.
Topics: Follow-Up Studies; Humans; Parkinson Disease; Trihexyphenidyl | 1954 |
Five year follow-up of artane treatment; the outcomes in 461 Parkinson cases.
Topics: Follow-Up Studies; Humans; Parkinson Disease; Parkinsonian Disorders; Trihexyphenidyl | 1953 |
A study of the effectiveness of drug therapy in parkinsonism.
Topics: Humans; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; Placebos; Scopolamine; | 1954 |
[Artane for treatment of Parkinson's syndrome].
Topics: Humans; Parkinson Disease; Trihexyphenidyl | 1955 |
[Pharmacokinetics in parkinsonism].
Topics: Anticonvulsants; Antipsychotic Agents; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Di | 1955 |
[P 119, a spasmolytic for the treatment of parkinsonism].
Topics: Parasympatholytics; Parkinson Disease; Parkinsonian Disorders; Trihexyphenidyl | 1955 |
Mental symptoms in parkinsonism following benzhexol hydrochloride therapy.
Topics: Humans; Mental Disorders; Parkinson Disease; Parkinsonian Disorders; Trihexyphenidyl | 1956 |
[An observation on the treatment of Parkinson's syndrome; results with the new drug ParKS 12].
Topics: Cardiovascular Agents; Muscle Relaxants, Central; Parkinson Disease; Piperidines; Trihexyphenidyl | 1956 |
Parkinsonism: treatment with curare.
Topics: Cardiovascular Agents; Curare; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; | 1956 |
Parkinsonism: treatment with curare.
Topics: Cardiovascular Agents; Curare; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; | 1956 |
Parkinsonism: treatment with curare.
Topics: Cardiovascular Agents; Curare; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; | 1956 |
Parkinsonism: treatment with curare.
Topics: Cardiovascular Agents; Curare; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; | 1956 |
[Study of combined therapy of parkinsonian conditions, especially postencephalitic conditions].
Topics: Autonomic Agents; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; Trihexypheni | 1956 |
[Study of combined therapy of parkinsonian conditions, especially postencephalitic conditions].
Topics: Autonomic Agents; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; Trihexypheni | 1956 |
[Study of combined therapy of parkinsonian conditions, especially postencephalitic conditions].
Topics: Autonomic Agents; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; Trihexypheni | 1956 |
[Study of combined therapy of parkinsonian conditions, especially postencephalitic conditions].
Topics: Autonomic Agents; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; Trihexypheni | 1956 |
Protection against reserpine-induced Parkinsonism.
Topics: Humans; Parkinson Disease; Parkinsonian Disorders; Reserpine; Trihexyphenidyl | 1957 |
Procyclidine hydrochloride (kemadrin) treatment of parkinsonism; result in 108 patients.
Topics: Parkinson Disease; Parkinsonian Disorders; Procyclidine; Trihexyphenidyl | 1957 |
[Cycrimine, a new drug in the treatment of Parkinson's disease & Parkinsonism].
Topics: Humans; Nervous System Diseases; Parkinson Disease; Piperidines; Trihexyphenidyl | 1957 |
[Parkinsonism-like symptoms caused by chlorpromazine therapy].
Topics: Chlorpromazine; Electroconvulsive Therapy; Humans; Parkinson Disease; Parkinsonian Disorders; Psycho | 1958 |
The use of kemadrin in the treatment of drug-induced parkinsonism; preliminary report.
Topics: Parkinson Disease; Parkinsonian Disorders; Procyclidine; Trihexyphenidyl | 1958 |
Anti-Parkinson drugs and their relationship to glaucoma.
Topics: Antiparkinson Agents; Cardiovascular Agents; Glaucoma; Muscle Relaxants, Central; Parkinson Disease; | 1958 |
Parkinsonism: drug therapy; neurosurgical therapy.
Topics: Cardiovascular Agents; Humans; Muscle Relaxants, Central; Parkinson Disease; Parkinsonian Disorders; | 1958 |
[Therapy for patients with early-stage Parkinson's disease].
Topics: Amantadine; Animals; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combinati | 2003 |
[Clinical study of trihexyphenyl-HCl therapy of the parkinson syndrome].
Topics: Biomedical Research; Parkinson Disease; Trihexyphenidyl | 1961 |
Slow-release trihexyphenidyl in Parkinson's disease.
Topics: Humans; Parkinson Disease; Patient Discharge; Trihexyphenidyl | 1962 |
[Pathogenesis and medical treatment of parkinsonism].
Topics: Humans; Imipramine; Parkinson Disease; Parkinsonian Disorders; Piperidines; Trihexyphenidyl | 1963 |
[Preparations for the treatment of Parkinsonism-cyclodol and ridinol].
Topics: Parasympatholytics; Parkinson Disease; Parkinsonian Disorders; Piperidines; Trihexyphenidyl | 1962 |
[Clinical experiences on comparative studies of the preparations. Parkan and Artane].
Topics: Arteriosclerosis; Humans; Parkinson Disease; Trihexyphenidyl | 1963 |
Acute suppurative parotitis associated with certain drugs in the treatment of parkinsonism.
Topics: Humans; Parasympatholytics; Parkinson Disease; Parkinsonian Disorders; Parotitis; Trihexyphenidyl | 1962 |
PARKINSON'S DISEASE.
Topics: Amitriptyline; Dextroamphetamine; Humans; Imipramine; Muscle Relaxants, Central; Neurosurgery; Orphe | 1963 |
EFFECTS OF TRIHEXYPHENIDYL HYDROCHLORIDE (ARTANE) ON PARKINSON'S DISEASE.
Topics: Parkinson Disease; Parkinsonian Disorders; Placebos; Trihexyphenidyl | 1964 |
ORPHENADRINE IN THE TREATMENT OF PARKINSON'S DISEASE.
Topics: Biomedical Research; Geriatrics; Orphenadrine; Parkinson Disease; Parkinsonian Disorders; Pharmacolo | 1964 |
Use of biperiden hydrochloride in Parkinson's disease.
Topics: Biperiden; Humans; Parkinson Disease; Trihexyphenidyl | 1960 |
Recurrent thioperazine-induced extrapyramidal reaction following placebo substitution for maintenance antiparkinson drug.
Topics: Antiparkinson Agents; Antipsychotic Agents; Atropine Derivatives; Extrapyramidal Tracts; Parkinson D | 1961 |
Withdrawal of maintenance antiparkinson drug in the phenothiazine-induced extrapyramidal reaction.
Topics: Antiparkinson Agents; Conduct Disorder; Humans; Parkinson Disease; Phenothiazines; Trihexyphenidyl | 1961 |
Paroxysmal exercise-induced dystonia as a presenting feature of young-onset Parkinson's disease.
Topics: Adult; Age Factors; Antiparkinson Agents; Basal Ganglia; Diagnosis, Differential; Dopamine Plasma Me | 2003 |
Therapy of Parkinson's disease.
Topics: Diphenhydramine; Encephalitis; Humans; Mephenesin; Muscle Rigidity; Pain; Parkinson Disease; Parkins | 1950 |
Artane in the treatment of Parkinson's disease.
Topics: Parkinson Disease; Parkinsonian Disorders; Trihexyphenidyl | 1951 |
How to treat parkinsonism.
Topics: Parkinson Disease; Parkinsonian Disorders; Trihexyphenidyl | 1951 |
Treatment of parkinsonism in a child.
Topics: Parkinson Disease; Parkinsonian Disorders; Trihexyphenidyl | 1952 |
[First personal impressions on the treatment of the parkinsonian syndrome with artane].
Topics: Humans; Parkinson Disease; Parkinsonian Disorders; Social Behavior; Trihexyphenidyl | 1951 |
Trihexyphenidyl (artane), stramonium, and nonchemotherapy of paralysis agitans.
Topics: Alkaloids; Datura stramonium; Muscarinic Antagonists; Parkinson Disease; Trihexyphenidyl | 1952 |
[Combined belladonna-artane in small doses in the treatment of post-encephalitic parkinsonism].
Topics: Alkaloids; Atropa belladonna; Humans; Muscarinic Antagonists; Parasympatholytics; Parkinson Disease; | 1951 |
Behaviour disorders associated with Artane treatment of post-encephalitic Parkinsonism.
Topics: Conduct Disorder; Humans; Mental Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; | 1952 |
Treatment with subthreshold doses of caffeine plus trihexyphenidyl fully restores locomotion and exploratory activity in reserpinized rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Diseas | 2004 |
[Treatment of Parkinson's syndrome by trihexylphenidyl (artane)].
Topics: Parkinson Disease; Parkinsonian Disorders; Trihexyphenidyl | 1950 |
[Tactile hallucinations induced by trihexyphenidyl in a patient with Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Female; Hallucinations; Humans; Parkinson Disease; Trihexyphenidyl | 2005 |
Artane in the treatment of Parkinson's disease; a report of its effectiveness alone and in combination with benadryl and parpanit.
Topics: Cyclopentanes; Diphenhydramine; Parkinson Disease; Parkinsonian Disorders; Trihexyphenidyl | 1949 |
Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
Topics: Aged; Anti-Infective Agents; Antiparkinson Agents; Antipsychotic Agents; Bacteriuria; Ciprofloxacin; | 2008 |
Loss of teeth with antidepressant drug therapy.
Topics: Dental Caries; Diphenhydramine; Humans; Imipramine; Male; Middle Aged; Parkinson Disease; Psychophar | 1967 |
Therapy of neurologic disorders in the elderly.
Topics: Aged; Amantadine; Anticoagulants; Brain Ischemia; Bromocriptine; Carbidopa; Dexamethasone; Drug Inte | 1984 |
Disturbance of recent memory function in parkinsonian patients on anticholinergic therapy.
Topics: Aged; Humans; Memory; Mental Recall; Paired-Associate Learning; Parkinson Disease; Trihexyphenidyl; | 1984 |
[Drug therapy of Parkinson disease and parkinson disease-like symptoms].
Topics: Adenylyl Cyclases; Animals; Aromatic-L-Amino-Acid Decarboxylases; Biperiden; Brain; Catechol O-Methy | 1981 |
[Neurological aspects and modern trends in therapy of Parkinson's disease].
Topics: Atropine; Biperiden; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Procyclidine; Trihexyp | 1980 |
Hereditary parkinsonism with multiple system degeneration: beneficial effect of anticholinergics, but not of levodopa.
Topics: Adult; Amantadine; Basal Ganglia; Carbidopa; Cerebellar Ataxia; Cholinergic Antagonists; Consanguini | 1994 |
"Apraxia of lid opening," a focal eyelid dystonia: clinical study of 32 patients.
Topics: Adult; Aged; Aged, 80 and over; Apraxias; Blepharospasm; Botulinum Toxins; Dose-Response Relationshi | 1994 |
Anticholinergics and dyskinesia.
Topics: Aged; Biperiden; Carbidopa; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; | 1994 |
Day-night variation of urine volume in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Male; Middle Age | 1994 |
Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease.
Topics: Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Trihexyp | 1993 |
[Rhythmical involuntary movement at rest associated with olivo-ponto-cerebellar atrophy (OPCA)].
Topics: Adolescent; Aged; Brain; Clonazepam; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; | 1993 |
Coexistence of Parkinson's disease and myasthenia gravis: a case report.
Topics: Brain; Cholinesterase Inhibitors; Female; Humans; Middle Aged; Myasthenia Gravis; Parkinson Disease; | 1993 |
Chronic dementia in Parkinson's disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination.
Topics: Aged; Biperiden; Blood Glucose; Brain; Cerebral Cortex; Dementia; Energy Metabolism; Female; Humans; | 1993 |
Impaired cognitive shifting in parkinsonian patients on anticholinergic therapy.
Topics: Aged; Cognition; Female; Humans; Male; Middle Aged; Orphenadrine; Parasympatholytics; Parkinson Dise | 1993 |
Positron emission tomography of reversible intellectual impairment induced by long-term anticholinergic therapy.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Humans; Male; Parkinson Disease; Time Factors; Tomo | 1995 |
Treatment of Parkinson's disease in a patient with acute intermittent porphyria.
Topics: Aged; Antiparkinson Agents; Benserazide; Chlorpromazine; Dopamine Antagonists; Drug Interactions; Fe | 1995 |
Effects of trihexyphenidyl and L-dopa on brain muscarinic cholinergic receptor binding measured by positron emission tomography.
Topics: Aged; Binding, Competitive; Brain; Female; Humans; Kinetics; Levodopa; Male; Middle Aged; Parkinson | 1994 |
Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion.
Topics: Aged; Amantadine; Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Humans; Inappropriate | 1998 |
Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Biotransformation; Corpus Striatum; D | 1998 |
The effect of trihexyphenidyl, an anticholinergic agent, on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease.
Topics: Cerebrovascular Circulation; Cholinergic Antagonists; Female; Humans; Male; Middle Aged; Oxygen Cons | 1999 |
The economic consequences of a drug-drug interaction.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Depression; Drug Interactions; Female; Fluoxetine; Halo | 2001 |
How to achieve maximum benefit for the patient with Parkinson's disease.
Topics: Aged; Amantadine; Carbidopa; Diagnosis, Differential; Histamine H1 Antagonists; Humans; Levodopa; Ne | 1976 |
A pseudohemipharetic form of Parkinson's disease.
Topics: Aged; Amantadine; Carbidopa; Diagnosis, Differential; Drug Therapy, Combination; Female; Functional | 1976 |
Uptake and efflux of 14-C-dopamine in platelets: evidence for a generalized defect in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood Platelets; | 1975 |
Parkinson's disease.
Topics: Amantadine; Benztropine; Humans; Levodopa; Parkinson Disease; Procyclidine; Trihexyphenidyl | 1977 |
Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor.
Topics: Aged; Basal Ganglia Diseases; Drug Therapy, Combination; Electromyography; Female; Humans; Levodopa; | 1979 |
Parkinson's disease.
Topics: Aged; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Male; Parkinson Dis | 1979 |
Western equine encephalitis with rapid onset of parkinsonism.
Topics: Adult; Carbidopa; Encephalitis Virus, Western Equine; Encephalomyelitis, Equine; Female; Humans; Lev | 1977 |
[Combined treatment of parkinsonism with L-dopa and Parkopan].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disea | 1977 |
Hereditary Parkinsonism-dystonia with sustained control by L-DOPA and anticholinergic medication.
Topics: Adolescent; Adult; Aged; Dopamine beta-Hydroxylase; Dystonia Musculorum Deformans; Female; Growth Ho | 1976 |
Drug therapy of parkinsonism.
Topics: Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior; Dopa Decarboxylase; Drug Interac | 1976 |
[Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
Topics: Acetylcholine; Adult; Aged; Amantadine; Antiparkinson Agents; Cholinesterases; Drug Therapy, Combina | 1976 |
Levodopa-induced myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Amantadine; Amphetamine; Animals; Benztropine; Dopamine Antagonists; Dose | 1975 |
Effect of anticholinergic drugs on gastro-intestinal absorption of L-dopa in rats and in man.
Topics: Administration, Oral; Adult; Aged; Animals; Atropine; Digestive System; Drug Interactions; Female; H | 1976 |
Neuroleptics and the corpus striatum: clinical implications.
Topics: Acetylcholine; Basal Ganglia Diseases; Benztropine; Corpus Striatum; Dopamine; Fluphenazine; Haloper | 1976 |
[Treatment of parkinsonism].
Topics: Amantadine; Benztropine; Biperiden; Humans; Levodopa; Orphenadrine; Parkinson Disease; Procyclidine; | 1976 |
A component analysis of the generation and release of isometric force in Parkinson's disease.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combina | 1992 |
Effects of treatment with trihexyphenidyl on cognitive function in early Parkinson's disease.
Topics: Adult; Aged; Cognition Disorders; Female; Humans; Intelligence Tests; Male; Memory Disorders; Middle | 1991 |
Exteroceptive suppression of the masseter and temporalis muscles and parkinsonian rigidity.
Topics: Adult; Aged; Amantadine; Basal Ganglia; Bromocriptine; Electric Stimulation; Electromyography; Femal | 1991 |
Anticholinergic-induced analgesia: possible role for the cholinergic system in abnormal sensory symptoms in Parkinson's disease.
Topics: Analgesia; Female; Humans; Male; Middle Aged; Pain; Palliative Care; Parasympathetic Nervous System; | 1986 |
Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction.
Topics: Aged; Attention; Drug Therapy, Combination; Female; Form Perception; Humans; Levodopa; Male; Middle | 1989 |
Parkinson's disease and myasthenia gravis: adverse effect of trihexyphenidyl on neuromuscular transmission.
Topics: Humans; Male; Middle Aged; Myasthenia Gravis; Neuromuscular Junction; Parkinson Disease; Synaptic Tr | 1987 |
[Parkinson's disease associated with trihexyphenidyl (THP) induced dysphonia plicae ventricularis].
Topics: Aged; Female; Humans; Movement Disorders; Parkinson Disease; Sulpiride; Tongue Diseases; Trihexyphen | 1988 |
Acute pharmacologic tests in cranial dystonia.
Topics: Adult; Aged; Basal Ganglia Diseases; Clonazepam; Diagnosis, Differential; Double-Blind Method; Femal | 1988 |
Adverse effect of benzhexol on memory in Parkinson's disease.
Topics: Humans; Memory; Parkinson Disease; Trihexyphenidyl | 1988 |
Pharmacologic treatment of parkinsonian tremor.
Topics: Amantadine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tr | 1986 |
Idiopathic dystonia-parkinsonism with marked diurnal fluctuation of symptoms.
Topics: Adult; Bromocriptine; Electromyography; Electrophysiology; Female; Humans; Levodopa; Male; Middle Ag | 1985 |
Parkinson's tremor, relief by an antiaminic drug (BC 105). Discussion on the biochemical pathogenesis of Parkinsonian tremor.
Topics: Adult; Aged; Benzocycloheptenes; Dihydroxyphenylalanine; Ergolines; Female; Histamine H1 Antagonists | 1972 |
[Dyskinesia induced by anticholinergic drugs--electrophysiological analysis].
Topics: Aged; Benztropine; Biperiden; Electromyography; Female; Humans; Male; Middle Aged; Movement Disorder | 1974 |
Abnormal involuntary movements induced by anticholinergic therapy.
Topics: Aged; Biperiden; Dibenzazepines; Female; Humans; Mastication; Middle Aged; Movement Disorders; Orphe | 1974 |
[Experimental testing of some piperidine propanol diastereomers in animals as potential parkinsonism drugs].
Topics: 1-Propanol; Animals; Central Nervous System; Ileum; Mice; Organ Culture Techniques; Parasympatholyti | 1971 |
[Treatment of Parkinson's disease].
Topics: Antidepressive Agents; Histamine H1 Antagonists; Humans; Muscles; Parkinson Disease; Trihexyphenidyl | 1966 |
The relationship between the inhibition of dopamine uptake and the enhancement of amphetamine stereotypy.
Topics: Amantadine; Amphetamine; Animals; Behavior, Animal; Chlorpheniramine; Dopamine; Dopamine Antagonists | 1971 |
Parkinsonism and hyperthyroidism.
Topics: Diazepam; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hyperthyroidism; Male; | 1974 |
3-O-Methyldopa in Parkinson's disease.
Topics: Antiparkinson Agents; Drug Antagonism; Drug Therapy, Combination; Humans; Levodopa; Methyldopa; Park | 1974 |
Fluphenazine-induced parkinsonism in the baboon: pharmacological and metabolic studies.
Topics: Animals; Basal Ganglia Diseases; Benztropine; Carbon Isotopes; Chromatography, Thin Layer; Feces; Fe | 1972 |
Permanent dementia in idiopathic Parkinsonism treated with levodopa.
Topics: Aged; Amantadine; Brain; Dihydroxyphenylalanine; Electroencephalography; Humans; Male; Parkinson Dis | 1973 |
Unilateral Parkinson's disease, clinical and neuropathologic findings. A case report.
Topics: Autopsy; Brain; Cerebral Ventricles; Dihydroxyphenylalanine; Humans; Male; Middle Aged; Neurons; Par | 1973 |
Levodopa and dopamine in cerebrospinal fluid.
Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benztropine; Carbidopa; Dihydroxyphenylalanine; | 1973 |
Sporadic and familial parkinsonism and motor neuron disease.
Topics: Aged; Amantadine; Amyotrophic Lateral Sclerosis; Cerebellar Diseases; Corpus Striatum; Dihydroxyphen | 1973 |
[Present-day treatment of parkinsonism in the aged].
Topics: Aged; Amantadine; Antiparkinson Agents; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Therapy, Combin | 1973 |
Comparison of the renin response to dopamine and noradrenaline in normal subjects and patients with autonomic insufficiency.
Topics: Adult; Aged; Autonomic Nervous System; Blood Pressure; Diet; Dopamine; Fecal Incontinence; Humans; H | 1974 |
Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
Topics: Aged; Amantadine; Cognition Disorders; Dihydroxyphenylalanine; Drug Therapy, Combination; Edema; Eye | 1974 |
Benzhexol-induced blindness in Parkinson's disease.
Topics: Aged; Blindness; Female; Glaucoma; Humans; Male; Middle Aged; Parkinson Disease; Time Factors; Trihe | 1972 |
Relationship between desipramine plasma levels and the effect in Parkinson's syndrome.
Topics: Adult; Aged; Contracture; Desipramine; Drug Synergism; Female; Humans; Male; Middle Aged; Paralysis; | 1972 |
Comparison of trihexyphenidyl and dihydromorphanthridine derivative in control of tremor of parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Dibenzazepines; Dimethylamines; Female; Humans; Male; Middle Aged | 1972 |
A comparative study of the effects of anti-parkinson drugs on the oxotremorine-induced EEG and muscular activities.
Topics: Animals; Diphenhydramine; Drug Antagonism; Electroencephalography; Male; Muscle Tonus; Muscles; Orph | 1971 |
Lack of indication for use of antiparkinson medication. A follow-up study.
Topics: Adolescent; Adult; Female; Follow-Up Studies; Humans; Intellectual Disability; Male; Mental Disorder | 1971 |
[Attempt at treating parkinsonism with L-dopa and Artane].
Topics: Aged; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Humans; Male; Middle Aged | 1971 |
[Action of amantadine on parkinsonian tremor].
Topics: Adult; Aged; Amantadine; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Promethazi | 1971 |
Withdrawal of antiparkinson drugs.
Topics: Biperiden; Butyrophenones; Female; Humans; Male; Parasympatholytics; Parkinson Disease; Psychotic Di | 1971 |
Parkinsonism and dopa.
Topics: Dihydroxyphenylalanine; Humans; New Zealand; Orphenadrine; Parkinson Disease; Parkinson Disease, Pos | 1969 |
[Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
Topics: Aged; Carboxy-Lyases; Desipramine; Dihydroxyphenylalanine; Discrimination, Psychological; Drug Syner | 1969 |
Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.
Topics: Brain; Dihydroxyphenylalanine; Dopamine; Drug Hypersensitivity; Female; Handwriting; Humans; Injecti | 1971 |
Transitory procaine-induced Parkinsonism.
Topics: Chronic Disease; Dihydroxyphenylalanine; Female; Humans; Middle Aged; Parkinson Disease; Parkinson D | 1971 |
[Treatment of parkinsonism with benzhexole (Artane and Artane-sequel)].
Topics: Humans; Parkinson Disease; Trihexyphenidyl | 1967 |
Parkinson's disease presenting as hypothyroidism.
Topics: Diagnosis, Differential; Female; Functional Laterality; Humans; Hypothyroidism; Male; Middle Aged; M | 1968 |
The parkinsonian tremor in sleep.
Topics: Aged; Electroencephalography; Eye Movements; Female; Humans; Male; Middle Aged; Movement; Parkinson | 1968 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine | 1968 |
Reversal of central anticholinergic syndrome in man by physostigmine.
Topics: Aged; Ataxia; Central Nervous System Diseases; Child; Cognition Disorders; Delirium; Female; Halluci | 1968 |
Antiparkinsonism drugs.
Topics: Antidepressive Agents; Atropine; Diphenhydramine; Humans; Orphenadrine; Parasympatholytics; Parkinso | 1965 |
Antiparkinsonism medication for the phenothiazine-induced pyramidal-extrapyramidal syndrome in elderly brain-damaged patients.
Topics: Aged; Brain Damage, Chronic; Chlorpromazine; Female; Humans; Male; Parkinson Disease; Perphenazine; | 1965 |
[Prolonged use of ponalid in extapyramidal drug-induced syndromes].
Topics: Humans; Movement Disorders; Parkinson Disease; Parkinson Disease, Secondary; Salivary Gland Diseases | 1966 |
Treatment of parkinsonism with artane and slow release artane.
Topics: Delayed-Action Preparations; Humans; Parkinson Disease; Trihexyphenidyl | 1966 |